KDIGO is updating the 2021 Clinical Practice Guideline for the Management of Glomerular Diseases on an ongoing, chapter-by-chapter basis. The KDIGO 2023 Clinical Practice Guideline for the Management of Antineutrophilic Cytoplasmic Antibody (ANCA) is now available for public review. We invite you to review this guideline chapter update and share your candid comments and suggestions. Based on your input, we will prepare a final revised version for publication. We kindly request that you submit your feedback no later than Monday, May 29.

Visit the KDIGO Glomerular Diseases Guideline website to download the guideline and to submit comments via the survey link.

Please note that by agreeing to provide feedback on a KDIGO draft guideline document, you permit KDIGO to acknowledge your participation as a reviewer in the final publication.

Thank you in advance for your time and support. We look forward to hearing from you.